Bank Of New York Mellon Corp Amarin Corp Plcuk Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.94 - $5.84 $184,328 - $273,218	-46,784 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$4.26 - $6.5 $9,947 - $15,177	2,335 Added 5.25%	46,784 $204,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $113,304 - $196,047	-8,128 Reduced 15.46%	44,449 $952,000
Q3 2019 Nov 07, 2019	SELL	$13.89 - $23.16 $9,209 - $15,355	-663 Reduced 1.25%	52,577 $797,000
Q2 2019 Aug 12, 2019	BUY	$16.27 - $20.51 $279,502 - $352,341	17,179 Added 47.64%	53,240 $1.03 Million
Q1 2019 May 14, 2019	SELL	$12.61 - $22.33 $16,771 - $29,698	-1,330 Reduced 3.56%	36,061 $749,000
Q4 2018 Feb 11, 2019	SELL	$12.41 - $22.98 $17,659 - $32,700	-1,423 Reduced 3.67%	37,391 $509,000
Q3 2018 Nov 09, 2018	BUY	$2.45 - $16.27 $95,094 - $631,503	38,814 New	38,814 $0

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.